University of North Carolina School of Medicine

Oncology & Cancer

Kinase test may yield big gains for drug-resistant cancers

In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases "en masse", enabling measurement of the mechanism ...

HIV & AIDS

Drug helps purge hidden HIV virus, study shows

A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.

page 4 from 19